This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2017 Remove BioTech Remove Drug Development Related Topics
Meaningful Use Health Information Life Science healthcare technology Interoperability EHR Telemedicine Healthcare IT Telehealth Pharmaceuticals More Related Topics >
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. After all of this time and energy expended, it’s only right that patients would be witness to accountability of pharma/biotech to incorporate our collective voice.

BioTech 144
BioTech Drug Development Meaningful Use Pharmaceuticals 144
article thumbnail

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Lloyd Price

DECEMBER 8, 2018

billion valuation in the last fundraising in early 2017, according to Lagniappe. Existing investors include biotech giant Celgene Corp. , But key facets of its business didn’t develop as planned, say people familiar with the company. That marks an 80% decline from the estimated $1.6 DNA-sequencing company Illumina Inc.,

Pharmaceuticals 56
Pharmaceuticals Life Science BioTech Drug Development 56
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024